| Radioiodinated Tau Imaging Agent III Molecular Modeling, Synthesis, and Evaluation of a New Tau Imaging Agent, [125I]ISAS in Post-Mortem Human Alzheimer’s … SA Sison, CG Paclibar, C Liang, J Mukherjee Molecules 29 (14), 3308, 2024 | | 2024 |
| [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease C Liang, CG Paclibar, NL Gonzaga, SA Sison, HS Bath, AP Biju, ... Neurology International 16 (2), 419-431, 2024 | 1 | 2024 |
| Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion … NM Shah, N Ghazaryan, NL Gonzaga, CG Paclibar, AP Biju, C Liang, ... Molecules 29 (1), 20, 2024 | 1 | 2024 |
| A simplified protocol for the automated production of 2‐[18F]fluoro‐3‐[2‐((S)‐3‐pyrrolinyl)methoxy]pyridine ([18F]nifene) on an IBA Synthera® module M Bhuiyan, J Souris, A Kucharski, R Freifelder, J Mukherjee, CT Chen Journal of Labelled Compounds and Radiopharmaceuticals 67 (1), 31-36, 2024 | | 2024 |
| Synthesis and Evaluation of Compound Targeting α7 and β2 Subunits in Nicotinic Acetylcholinergic Receptor K Singh, A Ngo, OV Keerthisinghe, KK Patel, C Liang, J Mukherjee Molecules 28 (24), 8128, 2023 | | 2023 |
| Evaluation of an Image-Derived Input Function for Kinetic Modeling of Nicotinic Acetylcholine Receptor-Binding PET Ligands in Mice M Zammit, CM Kao, HJ Zhang, HM Tsai, N Holderman, S Mitchell, ... International Journal of Molecular Sciences 24 (21), 15510, 2023 | | 2023 |
| [125I]INFT: Synthesis and Evaluation of a New Imaging Agent for Tau Protein in Post-Mortem Human Alzheimer’s Disease Brain RR Limpengco, C Liang, YK Sandhu, J Mukherjee Molecules 28 (15), 5769, 2023 | 1 | 2023 |
| Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain AU Syed, C Liang, KK Patel, R Mondal, VM Kamalia, TR Moran, ... International Journal of Molecular Sciences 24 (13), 10808, 2023 | 7 | 2023 |
| Multi-targeting agents for Alzheimer's disease therapy J Mukherjee, A Baranwal, H Ho, G Samra, K Dang, MR Felix US Patent 11,679,103, 2023 | | 2023 |
| Abnormal [18F]NIFENE binding in transgenic 5xFAD mouse model of Alzheimer's disease: In vivo PET/CT imaging studies of α4β2* nicotinic acetylcholinergic … C Liang, GA Nguyen, TB Danh, AK Sandhu, LL Melkonyan, AU Syed, ... Synapse 77 (3), e22265, 2023 | 5 | 2023 |
| Development of [124/125I]IAZA as a New Proteinopathy Imaging Agent for Alzheimer’s Disease T Reddy, M Iguban, L Melkonyan, J Shergill, C Liang, J Mukherjee MOLECULES 28 (2), 865, 2023 | 7 | 2023 |
| Trapping of nicotinic acetylcholine receptor ligands assayed by in vitro cellular studies and in vivo PET imaging HJ Zhang, M Zammit, CM Kao, AP Govind, S Mitchell, N Holderman, ... Journal of Neuroscience 43 (1), 2-13, 2023 | 9 | 2023 |
| Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [18F] Flotaza,[125I] IBETA,[124/125I] IPPI and … R Mondal, YK Sandhu, VM Kamalia, BA Delaney, AU Syed, GAH Nguyen, ... Biomedicines 11 (4), 1033, 2023 | 4* | 2023 |
| Elevated Monoamine Oxidase-A in Anterior Cingulate of Post-Mortem Human Parkinson’s Disease: A Potential Surrogate Biomarker for Lewy Bodies? J Mukherjee, L Reisha, C Liang, A Syed CELLS 11 (24), 4000, 2022 | 8 | 2022 |
| [124I]IBETA: A New Aβ Plaque Positron Emission Tomography Imaging Agent for Alzheimer’s Disease GAH Nguyen, C Liang, J Mukherjee Molecules 27 (14), 4552, 2022 | 12 | 2022 |
| Comparison of TSPO, MAO-A, TAU, and Aβ Amyloid in Post-Mortem Human Alzheimer’s Disease Anterior Cingulate A Syed, R Mondal, R Ladwa, C Liang, J Mukherjee Journal of Nuclear Medicine 63 (supplement 2), 2325-2325, 2022 | | 2022 |
| Monoamine Oxidase A as a Surrogate Biomarker for Lewy Body Distribution in Postmortem Parkinson’s Disease Brains R Ladwa, C Liang, J Mukherjee Journal of Nuclear Medicine 63 (supplement 2), 2504-2504, 2022 | | 2022 |
| [18F] Nifene binding is reduced in the hippocampus of a PS19 transgenic tau mouse model of Alzheimer’s disease. M Zammit, H Zhang, CM Kao, J Cui, S Mitchell, N Holderman, A McVea, ... Journal of Nuclear Medicine 63 (supplement 2), 2323-2323, 2022 | | 2022 |
| [18F] Flotaza binding to beta-Amyloid Plaques in Post-Mortem Human Alzheimer’s Disease Hippocampus A Sandhu, A Syed, T Moran, A Nguyen, C Liang, J Mukherjee Journal of Nuclear Medicine 63 (supplement 2), 2858-2858, 2022 | | 2022 |
| Evaluation of Nicotinic Acetylcholine Receptors in Taupathies J Mukherjee, C Liang, O Keerthisinghe, L Melkonyan Journal of Nuclear Medicine 63 (supplement 2), 2957-2957, 2022 | | 2022 |
